T1	Participants 36 82	recipients of extended criteria donor kidneys.
T2	Participants 386 545	Three hundred four patients entered the LTE (n = 104 MI; n = 113 LI; n = 87 CsA), and 260 continued treatment through year 5 (n = 91 MI; n = 100 LI; n = 69 CsA
